Simplex Trading
ADMA icon

Simplex Trading’s ADMA Biologics ADMA Stock Holding History

Simplex Trading’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Sell
27,876
-27,041
-49% -$247K ﹤0.01% 4514
2026
Q1 		$495K Buy
+54,917
New +$867K ﹤0.01% 3277
2025
Q4 		– Sell
-52,851
Closed -$891K – 8367
2025
Q3 		$774K Buy
+52,851
New +$906K ﹤0.01% 3312
2024
Q1 		– Sell
-14,714
Closed -$80.4K – 8724
2023
Q4 		$66K Buy
14,714
+13,021
+769% +$48.2K ﹤0.01% 5807
2023
Q3 		$6K Buy
+1,693
New +$6.52K ﹤0.01% 7495
2022
Q3 		– Sell
-9,070
Closed -$21.8K – 9788
2022
Q2 		$17K Buy
9,070
+957
+12% +$1.88K ﹤0.01% 7751
2022
Q1 		$14K Buy
8,113
+6,696
+473% +$10.4K ﹤0.01% 8565
2021
Q4 		$1K Sell
1,417
-181,779
-99% -$239K ﹤0.01% 10127
2021
Q3 		$291K Hold
183,196
– – ﹤0.01% 4948
2021
Q2 		$293K Buy
183,196
+12,832
+8% +$22.6K ﹤0.01% 5018
2021
Q1 		$299K Buy
+170,364
New +$390K ﹤0.01% 4146
2020
Q4 		– Sell
-414
Closed -$870 – 8245
2020
Q3 		$0 Sell
414
-113,949
-100% -$312K ﹤0.01% 7688
2020
Q2 		$335K Buy
114,363
+87,615
+328% +$252K ﹤0.01% 3395
2020
Q1 		$77K Buy
26,748
+21,746
+435% +$75.2K ﹤0.01% 4650
2019
Q4 		$20K Buy
+5,002
New +$21.8K ﹤0.01% 5936
2019
Q1 		– Sell
-284
Closed -$1K – 7042
2018
Q4 		$0 Sell
284
-5,379
-95% -$26.6K ﹤0.01% 6895
2018
Q3 		$35K Buy
+5,663
New +$32.6K ﹤0.01% 5496

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Simplex Trading's ADMA Position: Q2 2026 in Review

Simplex Trading reduced its ADMA Biologics (ADMA) stake by 49% in Q2 2026, selling an estimated $247K and leaving 27,876 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Simplex Trading first reported a position in ADMA in Q3 2018 and has held it in 17 quarters since. The position peaked at $774K in Q3 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Simplex Trading held 27,876 shares of ADMA Biologics worth $233K as of Q2 2026.
  • Simplex Trading sold 27,041 ADMA Biologics shares in Q2 2026, an estimated $247K.
  • ADMA Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4514 holding.
  • Simplex Trading first reported a position in ADMA Biologics in Q3 2018 and has held it in 17 quarters since.
  • Simplex Trading's ADMA Biologics position peaked at $774K in Q3 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.